Stonegate Initiates Coverage on Sirona Biochem Corp SBM
DALLAS, TX -- October 17th, 2024 -- Sirona Biochem Crop SBM: Stonegate Capital Partners initiates their coverage on Sirona Biochem Corp SBM.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- GlycoProteMim™ is a potential standout in the premium skincare market
- Sirona is targeting profitability by 2025, with expected revenue from Allergan Aesthetic and the commercialization of GlycoProteMim™ set to drive growth.
- Sirona's partnerships place it in a strong position to capture market share in the growing global skincare industry.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
Distributed by: Reportable, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
